Loading cancer entity…
Loading cancer entity…
Clinical trials
24 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02209428 | A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas | unknown | Phase 2 | 54 | Huashan HospitalOTHER | 1 | Feb 21, 2019 | clinicaltrials |
| NCT01089244 | FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma | unknown | — | 38 | Ludwig-Maximilians - University of MunichOTHER | 1 | Sep 22, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Feb 21, 2019source: clinicaltrials